Multicenter US clinical experience with the Scepter Mini balloon catheter.

Scepter balloon dual-lumen mini

Journal

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695

Informations de publication

Date de publication:
13 Apr 2024
Historique:
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 13 4 2024
Statut: aheadofprint

Résumé

Distal navigability and imprecise delivery of embolic agents are two limitations encountered during liquid embolization of cerebrospinal lesions. The dual-lumen Scepter Mini balloon (SMB) microcatheter was introduced to overcome these conventional microcatheters' limitations with few small single-center reports suggesting favorable results. A series of consecutive patients undergoing SMB-assisted endovascular embolization were extracted from prospectively maintained registries in seven North-American centers (November 2019 to September 2022). Fifty-four patients undergoing 55 embolization procedures utilizing SMB were included (median age 58.5; 48.1% females). Cranial dural arteriovenous fistula embolization was the most common indication (54.5%) followed by cranial arteriovenous malformation (27.3%). Staged/pre-operative embolization was done in 36.4% of cases; and 83.6% of procedures using Onyx-18. Most procedures utilized a transarterial approach (89.1%), and SMB-induced arterial-flow arrest concurrently with transvenous embolization was used in 10.9% of procedures. Femoral access/triaxial setups were utilized in the majority of procedures (65.5% and 60%, respectively). The median vessel diameter where the balloon was inflated of 1.8 mm, with a median of 1.5 cc of injected embolic material per procedure. Technical failures occurred in 5.5% of cases requiring aborting/replacement with other devices without clinical sequelae in any of the patients, with SMB-related procedural complications of 3.6% without clinical sequelae. Radiographic imaging follow-up was available in 76.9% of the patients (median follow-up 3.8 months), with complete occlusion (100%) or >50% occlusion in 92.5% of the cases, and unplanned retreatments in 1.8%. The SMB microcatheter is a useful new adjunctive device for balloon-assisted embolization of cerebrospinal lesions with a high technical success rate, favorable outcomes, and a reasonable safety profile.

Identifiants

pubmed: 38613371
doi: 10.1177/15910199241246135
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15910199241246135

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Mohamed M Salem (MM)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Paz Kelmer (P)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Georgios S Sioutas (GS)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Sophie Ostmeier (S)

Department of Radiology and Neurosurgery, Stanford University, Stanford, CA, USA.

Alex Hoang (A)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.

Gustavo Cortez (G)

Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, FL, USA.

Kareem El Naamani (K)

Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

Rawad Abbas (R)

Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

Ricardo Hanel (R)

Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, FL, USA.

Omar Tanweer (O)

Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.

Visish M Srinivasan (VM)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Pascal Jabbour (P)

Department of Neurosurgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

Peter Kan (P)

Department of Neurosurgery, University of Texas Medical Branch Galveston, Galveston, TX, USA.

Brian T Jankowitz (BT)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Jeremy J Heit (JJ)

Department of Radiology and Neurosurgery, Stanford University, Stanford, CA, USA.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.

Classifications MeSH